col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Value in Health
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―20 P26 The Practice of Face Masking Among Young Adults in South India: An Online Cross-Sectional Survey During Second Wave of COVID-19 J Kochuparambil, A Issac
2 [GO] 2022―Jan―20 POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19 S Jhamb, S Khan, H Taneja, A Sachdev, D Mazumder, A Buikema
3 [GO] 2022―Jan―20 POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19 E Mozaffari, Z Zhang, M Thrun, RL Gottlieb, DR Kuritzkes, PE Sax, et al. (+5)
4 [GO] 2022―Jan―20 POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19. A Santos, ÉSD Gonçalves, AJF Oliveira, DB Lima, KVMDS Noronha, MV Andrade
5 [GO] 2022―Jan―20 POSA424 Challenges of COVID-19 Research: Results from a Systematic Literature Review on COVID-19 and Asthma or COPD S Grieve, P Daniele, AP Rabe, A Forsythe
6 [GO] 2022―Jan―20 POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil JP Reis Neto, J Busch
7 [GO] 2022―Jan―20 POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States V Madge, N Bhardwaj, D Mazumder
8 [GO] 2022―Jan―20 P61 COVID-19 Concerns Experienced by Pregnant and Postpartum Women and Their Influence on Health-Related Quality-of-Life Swathi P Aytha, A Regan, E Grinshteyn, M Nosek, NY Gu
9 [GO] 2022―Jan―20 POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era? E Samuels, M Tang
10 [GO] 2022―Jan―20 POSB425 Methodological Challenges to Coronavirus Disease (COVID-19) Evidence Generation to Inform Health Technology Assessment (HTA) K Rtveladze, J Gaultney, CJ Crossman-Barnes, S Kamra, D Wright
11 [GO] 2022―Jan―20 POSA383 Identification of Risk Factors Associated with COVID-19 Hospitalization A Chopra, A Arora, I Kukreja, A Gupta, V Verma, A Shukla
12 [GO] 2022―Jan―20 P6 Projecting COVID-19 Hospitalizations and Deaths Under Scenarios of Vaccination in Jefferson County, Kentucky N Patel
13 [GO] 2022―Jan―20 POSA394 Mortality Curves Analysis of COVID-19 Hospitalizations in Oncologic Patients of a Private Health Care Plan in Brazil JP Reis Neto, J Busch, S Stefani
14 [GO] 2022―Jan―20 POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico A Ponce-de-León, A Azamar-Alonso, F Silva-Sanchez, R Chirino-Sprung, V Dominguez-Esquivel, S Rajme-López
15 [GO] 2022―Jan―20 POSC172 The Long-Term Acceptability of COVID-19 Hygiene Measures, for the UK General Population G Roberts, B English, J Mumford, A Mumford
16 [GO] 2022―Jan―20 POSA21 An In-Hospital Study to Trace the Risk Factors Associated with Adverse Drug Reactions during the Second Wave of COVID-19 in a Secondary Care Hospital in India J Kochuparambil, A Issac
17 [GO] 2022―Jan―20 POSA420 Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database Z Icten, M Friedman, J Menzin
18 [GO] 2022―Jan―20 POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany JA Gossmann, C Meier, RA Greiner, J Otto, E Shlaen, A Batscheider
19 [GO] 2022―Jan―20 POSA393 Online Risk Calculator Using Machine Learning for Prediction of Survival After Hospital Discharge from COVID-19 Infection JP Reis Neto, J Busch, FN Barcellos Filho, EMJDM Farina, MCM Ferreira
20 [GO] 2022―Jan―20 POSC324 Clinical Pharmacist Intervention to Improve the Administration of Injectable Antiviral Agents By Nurses in the Treatment of COVID-19 Infection. A Nidha, J Kochuparambil, A Issac
21 [GO] 2022―Jan―20 POSA384 Identification of Complications Associated with COVID-19 Infection from Claims Data A Arora, A Chopra, I Kukreja, V Verma, A Shukla
22 [GO] 2022―Jan―20 POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project Esposti L Degli, A Ghigi, DD Ancona, M Andretta, A Barbieri, F Bartolini, et al. (+16)
23 [GO] 2022―Jan―20 POSA173 Onset of Stroke in Patients with Post-COVID-19 Syndrome Following Hospitalisation for Severe COVID-19 Infection: A Systematic Literature Review C Fleming, A Chakraborty, T Jaiswal, P Patel, S Nair
24 [GO] 2022―Jan―20 POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients R Burruss, V Arikian, K Oleru, T Traurig, M Stranz, J Lindhorst
25 [GO] 2022―Jan―20 POSC254 The Impact of COVID-19 on European HTA Decisions C Watson, JL Petrie, JA Toomey, C Shaw
26 [GO] 2022―Jan―20 P63 Impact of COVID-19 on Health-Related Quality-of-Life in the United States, Sweden and Norway: A Cross-Country Comparison Using a Panel Survey J Chen, CL Gong, X Jiao, NK Zawadzki, U Persson, JW Hay, NY Gu
27 [GO] 2022―Jan―20 P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective J Mycka, R Dellamano, W Lobb, N Dalal, L Dellamano, E Pereira
28 [GO] 2022―Jan―20 POSC185 Healthcare Utilisation, Health Inequality and the Impact of COVID-19 on Idiopathic Pulmonary Fibrosis (IPF) Care in England: A Retrospective Cohort Study J Bevan
29 [GO] 2022―Jan―20 POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season A Ngami, F Guelfucci, F Bianic, P Net
30 [GO] 2022―Jan―20 POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States A Ngami, T Christie, G Ménin, F Guelfucci, F Bianic, P Net
31 [GO] 2022―Jan―20 P28 Impact of COVID-19 on Mental Health in Young Adults in the United States T Intermill, CL Gong, NY Gu
32 [GO] 2022―Jan―20 POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey T Denee, K Pungor, Y Kambarov, R Nissinen, J Lee, K Ampeh, F Parmeggiani
33 [GO] 2022―Jan―20 POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital L Cazin, A Ngami, L Parrenne, F le Mercier, F Guelfucci, F Bianic, et al. (+2)
34 [GO] 2022―Jan―20 P25 Impact of COVID-19 on the Health-Related Quality-of-Life of Pregnant and Postpartum Persons A Regan, P Aytha Swathi, M Nosek, NY Gu
35 [GO] 2022―Jan―20 P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data S Pacis, U Maywald, T Wilke, M Ghiani
36 [GO] 2022―Jan―20 POSB278 Modernising the Clinical Trial: A Shift to Decentralised Trials Driven By Advances in Technology and Catalysed By the COVID-19 Pandemic N Cross, N Kipentzoglou, J Whitehouse, A Satherley
37 [GO] 2022―Jan―20 P27 Vaccination Coverage Trends for Hepatitis B in Infants from the Brazilian and Colombian Expanded Immunization Program: A Real-World Analysis of COVID-19 Pandemic Impact P Lima, A Abreu, F Hernández, J Martins, B Kano, D Kashiura, G Julian
38 [GO] 2022―Jan―20 P22 COVID-19 Pandemic Impacts Volume of Evaluation & Management (E&M) Telehealth Visits within Community Oncology Practices M Karhade, N Mohammad, N Robert, N Wu, B Heller, S Alwardt, et al. (+3)
39 [GO] 2022―Jan―20 POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes S Pacis, U Maywald, T Wilke, M Ghiani
40 [GO] 2022―Jan―20 POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries ML Davis-Ajami, ZK Lu, J Wu
41 [GO] 2022―Jan―20 POSC218 Study of Antibiotic Consumption Trends in Public Pharmacies during the COVID-19 Pandemic in Ukraine O Zaliska, O Semenov, Z Zabolotnya, N Maksymovych, O Brezden, B Zaliskyy, I Mudrak
42 [GO] 2022―Jan―20 POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review D Jones, L Barham
43 [GO] 2022―Jan―20 POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies P Net, J de Renteria, F Bianic
44 [GO] 2022―Jan―20 P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany J Krieger, F Hardtstock, T Wilke, U Maywald
45 [GO] 2022―Jan―20 POSA363 Lasting Impacts of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B Halioua, A Astruc, M Gourdon, A Bombezin--Domino, L Radoszycki
46 [GO] 2022―Jan―20 POSA279 The Impact of the COVID-19 Pandemic on the MHRA’s Early Access to Medicines Scheme P Ruane, R Brown, LE Francis, L Sam
47 [GO] 2022―Jan―20 P62 The Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Melanoma - Findings from a UK Melanoma Registry M Heinrich, D Mulgina, A Kudlac, C Ouyang, M Larkin, A Ofori
48 [GO] 2022―Jan―20 POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case E Viayna, FJ Candel, D Callejo-Velasco, R Ramos, J San-Roman, P Barreiro, et al. (+5)
49 [GO] 2022―Jan―20 POSA247 Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies during COVID-19 Pandemic: A Single-Arm, Before-and-After Study R Murteira, S Romano, I Teixeira, H Galante, S Sousa, A Teixeira Rodrigues
50 [GO] 2022―Jan―20 POSB248 Medication Management Practices for Non-Communicable Diseases during the Second Wave of the COVID-19 Pandemic: A Snapshot of the European Situation P Kardas, JFM van Boven, B Wettermark, E Menditto, H Pinnock, I Tsiligianni, T Agh
51 [GO] 2022―Jan―20 POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients I Kukreja, A Chopra, A Arora, V Verma, A Shukla
52 [GO] 2022―Jan―20 POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients E Mozaffari, S Liang, HM Stewart, M Thrun, P Hodgkins, R Haubrich
53 [GO] 2022―Jan―20 POSC44 Extra Regional COVID-19 Patients Transfers: A Retrospective Analysis of Distance, Time and Cost for Train, Helicopter and Fixed-Wing Ambulances A Girault, P Chauvin, P Cucharero Atienza, N Sirven, O Grimaud
54 [GO] 2022―Jan―20 POSC1 The Influence of Diabetic History in the Prognosis of Hospitalized COVID-19 Patients: A Prospective Observational Study A Issac, J Kochuparambil
55 [GO] 2022―Jan―20 POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact LB Ferrario, F Schettini, E Porazzi, M Dalla Bona, MB Pagani, T Dezi, et al. (+8)
56 [GO] 2022―Jan―20 POSC17 A TARGETED LITERATURE REVIEW TO COMPARE COVID-19 SYMPTOM DIARIES AND PATIENT-REPORTED CONCEPT K. Jarodia, K. Scippa, K. Rudell
57 [GO] 2022―Jan―20 POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments X Sitavu-Radu, T Tulika, R Rajani, S Vasileva
58 [GO] 2022―Jan―20 POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated? A Vives, L Armand, L Radoszycki, O Wilczynski
59 [GO] 2022―Jan―20 POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study B Jahn, G Sroczynski, M Bicher, C Rippinger, N Mühlberger, J Santamaria, et al. (+3)
60 [GO] 2022―Jan―20 POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria M Traunfellner, F Meyer, E Walter
61 [GO] 2022―Jan―20 POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings R Harrell, A Kwon, M Karhade, N Robert, N Wu, B Heller, et al. (+3)
62 [GO] 2022―Jan―20 P20 Evaluating Preferences and the Effect of Altruism on COVID-19 Vaccine Decisions: A Discrete Choice Experiment M Kelley, EF Drabo, CL Gong
63 [GO] 2022―Jan―20 POSB193 COVID-19 Vaccine Development Pipeline: 2021 R Ahlawat, R Singhal, A Rajput, R Goyal
64 [GO] 2022―Jan―20 POSB222 Can Gene Therapy Prices Remain the Same? What We Have Learned from the COVID-19 Vaccines K Sigurðardóttir, O Sola-Morales
65 [GO] 2022―Jan―20 POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies Y Lee, K Lee, H Park, M Neese, ZM Khan
66 [GO] 2022―Jan―20 POSB328 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living with HIV/AIDS in the Era of COVID-19: A Qualitative Experience from a Low Middle-Income Country A Ahmed, J Dujaili, A Awaisu, FK Hashmi
67 [GO] 2022―Jan―20 POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative? JM Alves Junior, D Villagelin, FE Prota, A Chrispim, C Silva, E Yamanaka, et al. (+7)
68 [GO] 2022―Jan―20 POSC413 A Systematic Review of Real-World Clinical Practice Data in COVID-19: Non-Interventional Studies S Mishinova, J Gomon, A Kolbin, VV Strizheletsky, I Ivanov
69 [GO] 2022―Jan―20 P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective M Schöttler, S Van der Schans, M Postma, C Boersma
70 [GO] 2022―Jan―20 P23 Change in Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Heart Failure during the Coronavirus Pandemic in England: A Retrospective Cross-Sectional Study Utilising HES D Jones, L Barham
71 [GO] 2022―Jan―20 POSB178 Geographical Inequalities in Coronavirus (SARS-COV-2) Mortality in Europe D Elmer, D Endrei, T Csákvári, N Németh, L Horváth, N Danku, et al. (+2)
72 [GO] 2022―Jan―20 POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2 AF Cobre, A Junkert, MM Fachi, B Böger, M Surek, A Wiens, et al. (+2)
73 [GO] 2022―Jan―20 POSA210 Decentralized Study Methods: A Summary of the Regulatory Landscape in the SARS-COV-2 Era and Beyond A Bevan, M Baltezegar
74 [GO] 2022―Jan―20 POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection B Iacolare, V Perrone, D Sangiorgi, A Ghigi, E Giacomini, C Nappi, et al. (+16)
75 [GO] 2022―Jan―20 P24 Telehealth Access and Use by the U.S. Medicare Population during the Pandemic T Swenson
76 [GO] 2022―Jan―20 POSA234 The Value of a Large Care Network in Delivering Continuity of Care to Clinically Extremely Vulnerable People During a Global Pandemic: A UK Case Study S Boeger, E Busink, G Dewsnap, K Basnayake, M Beaumont
77 [GO] 2021―Dec―11 The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe Luz María Peña-Longobardo, Juan Oliva-Moreno, Beatriz Rodríguez-Sánchez
78 [GO] 2021―Dec―08 Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries Jichao Sun, Yefeng Zheng, Wenhua Liang, Zifeng Yang, Zhiqi Zeng, Tiegang Li, et al. (+4)
79 [GO] 2021―Oct―16 Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review Oscar Lau, Nirma Khatri Vadlamudi
80 [GO] 2021―Sep―30 Cost-Effectiveness of Coronavirus Disease 2019 Policy Measures: A Systematic Review Sophie Vandepitte, Tijs Alleman, Ingmar Nopens, Jan Baetens, Samuel Coenen, Delphine De Smedt
81 [GO] 2021―Aug―05 Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories J. Jaime Caro, Jörgen Möller, Vatshalan Santhirapala, Harpreet Gill, Jessica Johnston, Kariem El-Boghdadly, et al. (+3)
82 [GO] 2021―Aug―05 Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios William F. Vásquez, Jennifer M. Trudeau
83 [GO] 2021―Jul―31 Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic Brittany R. Lapin, Wai Hong Wilson Tang, Ryan Honomichl, Olivia Hogue, Irene L. Katzan
84 [GO] 2021―Jun―04 PNS21 Protection Motivation Theory in Predicting Intention to Engage in Protective Behaviors Against NOVEL Coronavirus Diseases (COVID-19) G. Adunlin, H. Galadima, C. Cropp, J.C. Cagle
85 [GO] 2021―Jun―04 PMU1 Evolving Access Under COVID-19 J. Cook
86 [GO] 2021―Jun―04 PNS36 VALUE Based Procurement: A Tool to Make Better Purchasing Decisions after COVID-19 G. Prada, C. Brabata, D. Guarin, R. Iunes, R. Lenz, V. Zamora Mesia
87 [GO] 2021―Jun―04 PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19 F. Kamgar, R. Hughes, S. Lucherini
88 [GO] 2021―Jun―04 PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review F. Caballol-Avendaño, A. Flores-Hoyos, J. Guerra-Cruz, V. Merillu-González, F. Morales-Vizcarra, K. Reynaldos-Grandón
89 [GO] 2021―Jun―04 PCV40 Cardiovascular Outcomes Associated with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis H. Alkofide, R. Almesned, L. Alnoghaimshi, Z. Alkherb, G. Alhindi, G. Korayem
90 [GO] 2021―Jun―04 PIN52 Effectiveness in Reducing the Risk of Death and Severity of a SET of Measures Against COVID-19 : The Case of an Insured Population in the Colombian Caribbean F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
91 [GO] 2021―Jun―04 IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample V. Divino
92 [GO] 2021―Jun―04 PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24 Sands-Lincoln. M, H. Huang, G.P. Jackson, S. Wang
93 [GO] 2021―Jun―04 PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level T. Nepomuceno, W.M. Silva, S.D.F. Gomes, T.F.O. Rodriguez
94 [GO] 2021―Jun―04 PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL J. Guo, J. Yang, J. Muzumdar, T. Park
95 [GO] 2021―Jun―04 PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, S. Ramachandran, E. Pittman, K. Bhattacharya, J.P. Bentley, B. Banahan, et al. (+2)
96 [GO] 2021―Jun―04 PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome D. Araja, U. Berkis, A. Lunga, M. Murovska
97 [GO] 2021―Jun―04 PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods D. Sheinson, Y. Meng, D. Elsea
98 [GO] 2021―Jun―04 PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era S.M. Preciado, K. Lotfi, E. Seoane-Vazquez, R. Rodriguez-Monguio, P. Brancazio
99 [GO] 2021―Jun―04 PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission J. Holloway, M. Cong, J. Ouyang, B. Vicidomina, S. Nigam
100 [GO] 2021―Jun―04 PCN238 COVID-19 Impact on Breast and Prostate Cancer Screening, Diagnosis, and Surgery: A Real-World Study from the Brazilian and Colombian Public Healthcare System Perspectives P.V.P. Lima, L. van der Werf, R. Ferreira, D. Kashiura, L. Ono, G. Julian, et al. (+2)
101 [GO] 2021―Jun―04 PNS14 Direct Medical Costs Related to COVID-19 in Colombia N. Alvis-Zakzuk, A. Florez-Tanus, D. Diaz-Jimenez, P. Chaparro-Narvaez, C. Castañeda-Orjuela, F. De La Hoz, et al. (+2)
102 [GO] 2021―Jun―04 PRS21 Quantifying the years of life lost due to COVID-19 in Colombia: preliminary estimates N. Alvis-Zakzuk, N. Alvis-Guzman, D. Diaz-Jimenez, C. Dueñas Castell, J. Rojas-Suarez, J.C. Fernandez Mercado, et al. (+3)
103 [GO] 2021―Jun―04 PIN32 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in Europe and Asia E. Achter, Y. Shen, R. Goldgrub, R. Kendall, D. Shah
104 [GO] 2021―Jun―04 PDB48 Increased Mortality of COVID-19 in Patients with Diabetes: A Retrospective Cohort Study in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
105 [GO] 2021―Jun―04 PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries F. Huang, G. Feng, T. Liu, Q. Chen, T. Jian, Q. Zhong, et al. (+4)
106 [GO] 2021―Jun―04 PIN22 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in the USA Y. Shen, R. Goldgrub, E. Achter, R. Kendall, D. Shah
107 [GO] 2021―Jun―04 PIN42 Molecular Testing Dynamics Is Reactive to COVID-19 Incidence: Observations from the Colombian Experience A. Lozano, J. Zakzuk, F. Salcedo Mejía, L. Moyano, N. Alvis-Zakzuk, N.R. Alvis-Zakzuk, N. Alvis-Guzman
108 [GO] 2021―Jun―04 IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review M. Podolsky, D. Kim, P.J. Neumann
109 [GO] 2021―Jun―04 PIN44 COVID-19 Knowledge, and Mental Health IMPACT Assessment in Haiti Y. Gousse, T. Jean
110 [GO] 2021―Jun―04 PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study P.B. Samaksha, R.K. Puvvada
111 [GO] 2021―Jun―04 PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis E. Guidotti, S. Manetti, M. Vainieri, F. Attanasio, N. Orsini
112 [GO] 2021―Jun―04 PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria F. Fatoye, T. Gebrye, O.O. Arije, C. Fatoye, O. Onigbinde, C. Mbada
113 [GO] 2021―Jun―04 PIN77 Engagement in Preventive Behaviors Following Exposure to COVID-19 News on Social Media T. Park, I. Ju, J. Ohs, A. Hinsley, J. Muzumdar
114 [GO] 2021―Jun―04 PMU48 The IMPACT of COVID-19 on European Health Technology Assessments P. Wagner, J. Zlateva, A. van Engen, S. Plantör
115 [GO] 2021―Jun―04 PMU45 The Impact of COVID-19 on Patient Management across the EU and US J. Piercy, E.A. Holdsworth, J. Austin, M.J. Hughes, K. Khela, G. Taylor-Stokes, J. Hall
116 [GO] 2021―Jun―04 PNS67 Gaining Trust in the Use of Virtual Meetings for Health Technology Assessment during the COVID-19 Pandemic J. Dickson, M. Pierre, L. Lockhart, J. McCormack
117 [GO] 2021―Jun―04 PNS56 Survey of the Awareness of Pharmacists about Quarantine Measures during the COVID-19 Pandemic O. Semenov, O. Zaliska, N. Maksymovych, V. Huz, Z. Zabolotnya
118 [GO] 2021―Jun―04 PMU58 Americans' Health Priorities during the COVID-19 Pandemic J. Cook, M. Pittaoulis, K. Gilchrist, J. Alderfer, M. Sapia
119 [GO] 2021―Jun―04 PMH24 Demographic and Clinical Factors Associated with Post Traumatic Stress Disorder (PTSD) during the COVID-19 Pandemic B.L. Rosario, H. Huang, G.P. Jackson, B. Kolt, S. Wang
120 [GO] 2021―Jun―04 PIN8 Application of Innovative Pricing in Response to the COVID-19 Pandemic C. Akunne, B. Connelly, S. Bathija
121 [GO] 2021―Jun―04 PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA G. Feng, F. Huang, Q. Chen, Q. Zhong, T. Liu, D. Hao, et al. (+3)
122 [GO] 2021―Jun―04 PRS32 Management Of The Covid-19 Pandemic Around Public Health: Ethical Perspectives C. Alcayaga, V. Loor-Sánchez, N. Oyarce-Hormazábal, M.P. Riveros-Riveros, K. Reynaldos-Grandón
123 [GO] 2021―Jun―04 PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
124 [GO] 2021―Jun―04 PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil? R. Arcaro, C.R. Pereira da Veiga, C. Da Veiga
125 [GO] 2021―Jun―04 PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia J. Pesa, J.N. Liberman, M. Petrillo, C. Ruetsch
126 [GO] 2021―Jun―04 PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization P. Arora, J. Ha, D. Mehta
127 [GO] 2021―Jun―04 PUK19 DATA Quality Considerations for Determining the IMPACT of the COVID-19 Pandemic on Outpatient Visits and Procedures in the United States P. Brendel, R. Jain, A. Lien, D. Lee, J.B. Shelton, R. Fang, et al. (+4)
128 [GO] 2021―Jun―04 PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States B. Halioua, J. Zetlaoui, A. Astruc, M. Harrizi, A. Bombezin--Domino, L. Radoszycki
129 [GO] 2021―Jun―04 PIN20 Predicting the IMPACT of Vaccination Strategies in the COVID-19 Pandemic Using a Susceptible-Exposed-Infectious-Removed (SEIR) MODEL W. Song, Y. Yi
130 [GO] 2021―Jun―04 PCN120 Clinical and Economic Consequences of Delayed Care Due to the COVID-19 Pandemic- Focus on Mammograms and Breast Cancer K. Infante, N. Eslami, S. Garfield
131 [GO] 2021―Jun―04 PIN47 COVID-19 Patient Severities in Japanese EMR M. Okada, S. Wada, M. Isshiki, S. Utsunomiya, T. Akiyama, K. Hamada, S. Demiya
132 [GO] 2021―Jun―04 PIN74 Health-Related Quality of Life (HRQoL) in COVID-19 Patients - a Systematic Literature Review N. Goli, N. Kayam, N. Kumar, D. Shah
133 [GO] 2021―Jun―04 PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases S.W. Kim, T. Ishii, S. Takeno, Y. Kado, Y. Tamai, T. Akiyama, et al. (+2)
134 [GO] 2021―Jun―04 PIN64 Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System V. Kumar, L. Rasouliyan, S. Long, M.B. Rao
135 [GO] 2021―Jun―04 IN1 Treatment Journey of COVID-19 Patients in Hospital Settings R. Moon, N. Rosenthal, H. Brown
136 [GO] 2021―Jun―04 IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States F. Sun, S. Jeyakumar, N. Smith
137 [GO] 2021―Jun―04 ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records X. Marinaro, Z. Meng, X. Zhang, K. Lodaya, D.K. Hayashida, S. Munson, F. D'Souza
138 [GO] 2021―Jun―04 PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature S. Iloanusi, O. Mgbere, E.J. Essien
139 [GO] 2021―Jun―04 PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System R. Ivos, I. Ribeiro-Vaz, J. Polónia, A. Silva
140 [GO] 2021―Jun―04 PRS30 COVID-19 RAPID Antigen Test False Positives and False Negatives Reported to the FDA Manufacturer and User Facility Device Experience Database M. Zettler, A. Gajra, B. Feinberg
141 [GO] 2021―Jun―04 PIH22 Efficacy Of Telephone-Based Educational Intervention On Knowledge Transfer Of COVID-19 Related Health Topics To Elderly Citizens In Hong Kong: A Pilot Study M.Y. Fung, Y.H. Lee, Y.T.A. Lee, M.L. Wong, J.T.S. Li, V. Lee
142 [GO] 2021―Jun―04 PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey N.J.R. Iloanusi, S. Iloanusi, O. Mgbere, A.I. Ajayi, E.J. Essien
143 [GO] 2021―Jun―04 PIN83 The COVID-19 Research Database: Building One of the Largest PRO Bono Real-World DATA Repositories A. Talwai, V. Wing, Y. Itzkovich, A. Galaznik, A. Chatterjee, R. Jain, J. LaBonte
144 [GO] 2021―Jun―04 PNS105 Patient Preferences and Feedback Regarding Daily Reporting of COVID-19 Symptoms Using Personal Smartphones for the Obvio-19 Study S. Dallabrida, H. Linke, P. Shah, M. Culbreth-Notaro
145 [GO] 2021―Jun―04 PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine O. Blavatska, I. Blavatskyi
146 [GO] 2021―Jun―04 PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America M.A. Espinoza, J. Guzman, J. Soto, G. Hernandez, D. Guarin, V. Boers Trilles, M. Martin De Bustamante
147 [GO] 2021―Jun―04 PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review O. Lau, N. Vadlamudi
148 [GO] 2021―Jun―04 PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults K. Rajagopalan, B. Mahadik
149 [GO] 2021―Jun―04 PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World C. Hildreth, K. Infante, N. Eslami, S. Garfield
150 [GO] 2021―Jun―04 PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods S. Emerson, K. Johnston, A. Howarth, J. Schneider, M. Friesen, S. Szabo
151 [GO] 2021―Jun―04 PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review U. Abubakar, M. Hammad
152 [GO] 2021―Jun―04 PND48 Real World Data and COVID-19: Healthcare Impact in Emergency Care, Stroke Emergency Care and Stroke-Related Deaths in Chile L. Paez, R. Lenz, D. Paredes
153 [GO] 2021―Jun―04 PIN59 COVID-19: The Real-World Hospitalized Patient Experience L. Rasouliyan, V. Kumar, S. Long, M.B. Rao
154 [GO] 2021―Jun―04 PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19? K. Hernández, D. Paredes, R. Lenz
155 [GO] 2021―Jun―04 PMH18 Emotional Well-Being Among Pharmacy Students during the COVID Pandemic M. Zakeri, La Cruz A De, D. Wallace, S.D. Sadeghi, S.S. Sansgiry
156 [GO] 2021―Jun―04 MT1 Telehealth Utilization and Multiple Sclerosis Imaging Utilization in Four MS Centers during the COVID Pandemic: Real-world evidence from the MS-CQI improvement research collaborative. A. Chen, M. Molaei, A. Vaeth, K. Walsh, B. Oliver
157 [GO] 2021―Apr―19 Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic Jagpreet Chhatwal, Maarten J. Postma
158 [GO] 2021―Mar―11 Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands Niek Mouter, Marion Collewet, G. Ardine de Wit, Adrienne Rotteveel, Mattijs S. Lambooij, Roselinde Kessels
159 [GO] 2021―Mar―10 Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs Charles F. Manski, Aleksey Tetenov
160 [GO] 2021―Mar―09 Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States Anirban Basu, Varun J. Gandhay
161 [GO] 2021―Mar―06 Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study Benjamin Gravesteijn, Eline Krijkamp, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie Bruinsma, et al. (+7)
162 [GO] 2021―Feb―21 Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies Jidi Zhao, Huajie Jin, Xun Li, Jianguo Jia, Chao Zhang, Huijuan Zhao, et al. (+9)
163 [GO] 2021―Feb―21 How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Adrian Towse, Kalipso Chalkidou, Isobel Firth, Hannah Kettler, Rachel Silverman
164 [GO] 2020―Dec―11 PIN166 Health-Related Quality of Life (HRQOL) Outcomes and Potential Interventions in Patients Diagnosed with COVID-19. M. Sehgal, V. Pandey
165 [GO] 2020―Dec―11 PMD34 RAPID Medtech Innovation Briefings for COVID-19 R. Owens, Y. Wang, K. Carter
166 [GO] 2020―Dec―11 PIN170 The NOVEL Coronavirus Disease (COVID-19): Impacts on TESTS and Hospitalizations Performance in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
167 [GO] 2020―Dec―11 PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System S. Boeger, J. Petrovic, E. Busink, C. Apel, F. Kircelli, R. Pohlmeier
168 [GO] 2020―Dec―11 PIN167 Patient-Reported Outcomes to Capture the Signs, Symptoms and Impacts of COVID-19 and the IMPACT of the Pandemic on People with and without Infection M. Reaney, K. Heuer, J. Turnbull, J. Paty
169 [GO] 2020―Dec―11 CO2 WHEN Could a Second Wave of COVID-19 Appear in Germany and How Strong Will IT be? a Simulation Analysis S. Walzer
170 [GO] 2020―Dec―11 PIN120 The IMPACT of LONG-TERM Exposure to PM2.5, PM10 and NO2 Air Pollutants on the Age-Adjusted Mortality RATE of COVID-19 Based on the Example of Poland. A. Musiałek, A. Nosowicz
171 [GO] 2020―Dec―11 PIN122 Racial Disparity in COVID-19 Burden at the US Epicenter M. Bhattacharyya, R. Bhattacharyya, L.E. Miller, A.L. Miller, C. Stewart, S. Rojanasarot
172 [GO] 2020―Dec―11 PIN78 County-level differences in COVID-19 cases and fatalities in Germany A. Batscheider, J.A. Gossmann, R.A. Greiner, E. Shlaen, B. Antoni, D. Böckmann, et al. (+2)
173 [GO] 2020―Dec―11 PIN81 Within Country Regional Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in Hungary I. Boncz, A. Sebestyén, J. Betlehem, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
174 [GO] 2020―Dec―11 PIN112 Geographical Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in the European Union I. Boncz, E. Dora, A. Sebestyén, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
175 [GO] 2020―Dec―11 CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints Z. Kocaata, I. Simankova, T. Wilke
176 [GO] 2020―Dec―11 PNS245 Do Patient Preferences Change in a Pandemic? Exploring Italian Patient Reported Experience DATA during the COVID-19 Crisis K. Jamieson Gilmore, S. De Rosis, S. Nuti
177 [GO] 2020―Dec―11 PIN124 Analysis of Race and Ethnicity of COVID-19 Deaths in the United States C. Xavier, R. Rasu
178 [GO] 2020―Dec―11 PIN114 Estimation of Quality-Adjusted Life YEARS (QALY) Losses Associated with COVID-19 Deaths in Ukraine V. Serediuk, O. Piniazhko, O. Topachevskyi, T. Dumenko, L. Kovtun
179 [GO] 2020―Dec―11 PIN117 Identification of Patients with COVID-19 Infection Prior to the New COVID-19 Diagnostic Code - a Premier Database Analysis. C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+4)
180 [GO] 2020―Dec―11 PRS41 Understanding the Clinical Burden of ACUTE Respiratory Distress Syndrome (ARDS) in a COVID-19 Era - a Targeted Search and Epidemiological MODEL D. Tomaras, S. Harricharan, G. Tremblay, F. Anna
181 [GO] 2020―Dec―11 PCN224 An Italian Experience: How the COVID-19 Era HAS Modified the Radiological Activity in a Cancer Hospital A. Rossi, A. Prochowski Iamurri, C. Cerchione, N. Gentili, V. Danesi, M. Altini, et al. (+2)
182 [GO] 2020―Dec―11 PNS10 Research in the COVID-19 Era: Accelerating the Shift in the Research Paradigm from Traditional Towards Digital/Virtual Solutions D. Stein, M. Baltezegar
183 [GO] 2020―Dec―11 PIN178 Impact of Selected Comorbidities on Healthcare Resource Utilization Among Hospitalized Patients with COVID-19 in a US Population Z. Icten, I. Livingstone, J. Menzin
184 [GO] 2020―Dec―11 PMH16 Productivity, Depression, and Measures to Reduce Social IMPACT: The Economic IMPACT of COVID-19 in Brazil R. Andrade, D. Sansone, D. Farah, R. Garcia, G. Tannus, M. Fonseca
185 [GO] 2020―Dec―11 PIN90 Characteristics of Patients Died Due to Coronavirus Disease 2019 (COVID-19) in Hungary I. Boncz, J. Betlehem, E. Dora, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
186 [GO] 2020―Dec―11 PIN65 Socio-Economic Burden of COVID-19 in Russian Federation A. Kolbin, J. Gomon, Y. Balykina, D. Belousov, I. Ivanov
187 [GO] 2020―Dec―11 PIN75 Characteristics of Patients Diagnosed with COVID-19 in the US: A Descriptive Claims-Based Study from a National Perspective V. Divino, Y. Wang, C. Beggs, M. DeKoven
188 [GO] 2020―Dec―11 PIN87 Comparing Methodologies to Predict Incidence of COVID-19 in US Counties P. Coplan, S. Shah, A. Bhardwaj, A. Gurubaran, H. Dwarakanathan, G. Cafri, et al. (+5)
189 [GO] 2020―Dec―11 IN3 Impact of Government Measures on COVID-19 Incidence of Reported New Cases: An Analysis of 9 Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
190 [GO] 2020―Dec―11 PIN17 Healthcare Resource Utilization and Cost in Patients with Inpatient Mortality Due to COVID-19 Infection C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+5)
191 [GO] 2020―Dec―11 PIN82 The Influence of Social Distancing on COVID-19 Infections in the U.S. P. Coplan, G. Cafri, R. Khanna, A.S. Chitnis, B. Nandi, H. Dwarakanathan, et al. (+5)
192 [GO] 2020―Dec―11 PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States J. Chhatwal, O. Dalgic, P. Mueller, M. Adee, Y. Xiao, M.A. Ladd, et al. (+2)
193 [GO] 2020―Dec―11 PMH29 To Assess the Psychological IMPACT of COVID-19 Lockdown Among Healthy Individuals in India. S. P.B., K. Undela, R.K. Puvvada, B. Gupta, K. Manohar Rao, S. Palaksha
194 [GO] 2020―Dec―11 PIN139 The Cost-Effectiveness of COVID-19 Lockdowns in the United States R. Becker
195 [GO] 2020―Dec―11 PIN85 The Application of Global Influenza Pandemic Mortality Progression and Vaccine Production Strategies As Analogues for COVID-19 Management and Understanding. C. Fidler
196 [GO] 2020―Dec―11 CO3 Effectiveness of Government Measures to Reduce COVID-19 Mortality across 5 Different Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
197 [GO] 2020―Dec―11 PRS56 Cost-Effectiveness of Social Distancing to Reduce COVID-19 Mortality in the United States B. Bloudek, K. Migliaccio-Walle, P.J. Barrett, V. Nguyen, L. Bloudek
198 [GO] 2020―Dec―11 PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities M. Thomas, P. Craddy, G. Foxon
199 [GO] 2020―Dec―11 PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer P. Chopra, Y. Zhai, M. Myers
200 [GO] 2020―Dec―11 PCN293 Understanding Real-World Experiences and Impacts of COVID-19 on Patients with Breast Cancer: A Social MEDIA Listening Analysis S. Halhol, M. Raluy-Callado, M. Oguz, A. Booth
201 [GO] 2020―Dec―11 PNS263 Pandemics and Access to Care: Use of Real-World DATA to Examine the IMPACT of COVID-19 on Pharmacy Visits in JAPAN M. LoPresti, T. Seo, N. Sato
202 [GO] 2020―Dec―11 PMU84 IMPACT of COVID-19 on Physician Engagement and Life Science Companies' Digital and Operational Strategy N. Eslami, B. Harris, V. Parris, P. Sharan, S. Butler, K. Infante, et al. (+3)
203 [GO] 2020―Dec―11 PMD42 The IMPACT of COVID-19 on Telemedicine in Ophthalmology: A Literature Review D. O'Boyle, F. Carones, K. Darcy, B.S. Malyugin, R. Rejdak, L. Moccaldi, F. Vidal Aroca
204 [GO] 2020―Dec―11 PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies C. Teale, A. Roldan-Gomendio, S. Heinz, C. Sayadian, N. Jimenez
205 [GO] 2020―Dec―11 PIN123 How Much Will the COVID-19 Outbreak Have Cost the German Health Care System in the First Months Since the Outbreak? S. Walzer, L. Vollmer, S. Krenberger
206 [GO] 2020―Dec―11 PSU20 Attitude of Hungarian Adults Towards Emergency Plans before COVID-19 Outbreak in Hungary A. Kovács, A. Oláh, A. Pakai, E. Inhoff, G. Far, K. Wirthné-Gyergyák, et al. (+2)
207 [GO] 2020―Dec―11 PIN173 Studying Fake News on Twitter during the COVID-19 Pandemia in France A. Gedik, P. Foulquié, S. Renner, A. Mebarki, N. Texier, S. Schück
208 [GO] 2020―Dec―11 PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic L. Chillotti, N. Largeron, G. Olivera
209 [GO] 2020―Dec―11 PIN126 Russian Mandatory Medical Insurance System Response to COVID-19 Pandemic M. Avxentyeva, V. Omelianovskiy, I. Zhelezniakova
210 [GO] 2020―Dec―11 PIN133 Medical Human Resource NEEDS of Chinese Health Professionals during the COVID-19 Pandemic. W. Hao, Z. Zhuang, W.K. Ming
211 [GO] 2020―Dec―11 PIN152 How Much Does a Life Cost? Lessons from the COVID-19 Pandemic A. Estévez-Carrillo, M. Cerezales, C. Crespo
212 [GO] 2020―Dec―11 PMD33 Estimating Societal Costs Associated with Vision Loss and Delayed Cataract Surgery: The Potential IMPACT of the COVID-19 Pandemic. D. O'Boyle, R. Busutil, L. Moccaldi
213 [GO] 2020―Dec―11 PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic T. Nepomuceno, W.M.D.N. Silva, L.G.D.O. Silva
214 [GO] 2020―Dec―11 PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic K. Athanasakis, N. Nomikos, K. Souliotis, J. Kyriopoulos
215 [GO] 2020―Dec―11 PNS126 Simpli - a Capacity Simulator for Evaluating Measures to Reduce the Backlog of Hospital Services after the COVID-19 Pandemic C. Bandeiras, F. Oliveira, M. Mota, R. Moita Fidalgo, A. Oliveira, C. Franco, et al. (+4)
216 [GO] 2020―Dec―11 PUK21 The VALUE of a Sustainable and Resilient Technical Service Network and Its Importance in Times of the COVID-19 Pandemic C. Hornig, E. Busink, B. Lababidi, M. Luckau, T. Pohl, C. Mutz
217 [GO] 2020―Dec―11 SP3 Should I Choose Artificial Intelligence or Clinicians' Diagnosis? a Discrete Choice Experiment of Patients' Preference UNDER COVID-19 Pandemic in China T. Liu, W. Tsang, F. Huang, W.K. Ming
218 [GO] 2020―Dec―11 PIN49 Influenza Vaccination and Its IMPACT on the Availability Intensive Care Unit BEDS during the COVID-19 Pandemic in Colombia M. Pareja, S. Londono, M. Moreno
219 [GO] 2020―Dec―11 PCV78 Clinical Pharmacists Assistance during COVID-19 Pandemic in Patients with ACUTE Coronary Syndrome at a Tertiary Care Hospital in India. O. Gona, R. Madhan
220 [GO] 2020―Dec―11 PIN154 QALY Losses Attributable to COVID-19 Pandemic in Spain V. Hernando, M. Brosa
221 [GO] 2020―Dec―11 PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B. Halioua, J. Zetlaoui, A. Astruc, T. Lévy-Heidmann, D. Testa, A. Bombezin--Domino, L. Radoszycki
222 [GO] 2020―Dec―11 PMU109 IMPACT of the COVID-19 Pandemic on Patients with Immune-Mediated Inflammatory Diseases Taking a Biologic Therapy B. Halioua, J. Zetlaoui, A. Astruc, D. Testa, A. Bombezin--Domino, L. Radoszycki
223 [GO] 2020―Dec―11 PMH25 The IMPACT of the COVID-19 Pandemic on the Mental Health of US Adults: A CROSS-Sectional Study A. Morlock, R. Morlock, S. Holmstrom
224 [GO] 2020―Dec―11 PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis W. Padula, S. Malaviya, N. Reid, F. Chingcuanco, J. Ballreich, J. Tierce, G.C. Alexander
225 [GO] 2020―Dec―11 PCN216 An Innovative Organization MODEL to Face Risks Reduction Challenges in an Italian Cancer Center during the COVID-19 Pandemic: A Risk Reduction Estimation Study N. Gentili, A. Roncadori, I. Massa, C. Florescu, L. Bertoni, F. Galardi, et al. (+7)
226 [GO] 2020―Dec―11 PCN353 Oncology Treatments during COVID-19 Pandemic: IMPACT in a Health Care PLAN in Brazil J.P. Reis Neto, J. Busch
227 [GO] 2020―Dec―11 PNS116 Maintaining Routine Healthcare for Chronic Medical Conditions during the COVID-19 Pandemic: What WE CAN Learn from Australia Z.M. Thet Lwin, T.C. Higgins, K. Winn, K.H. Naing
228 [GO] 2020―Dec―11 PIN8 A MODEL for Estimation of Possible COVID-19 Patient Numbers in Turkey S. Öztopçu, E.B. Karahan, S. Ökçün, M. Kurnaz, G. Oğuzhan, Z. Caliskan, G. Kockaya
229 [GO] 2020―Dec―11 PDB45 Obesity: A Major Risk Factor for Adverse Outcomes Among Young COVID-19 Patients R. Kashambwa, Z. Drebert
230 [GO] 2020―Dec―11 PIN108 Using the Apriori Algorithm to Identify Risk Factors Associated with Survival and Mortality Among COVID-19 Patients A. Vashisht, C. Holy, S. Shah, N. Elangovanraaj, S. Johnston, P. Coplan
231 [GO] 2020―Dec―11 PIN171 A Real-World DATA Analysis of Mortality and Heart Arrhythmia Risk in Hospitalized COVID-19 Patients Treated with Hydroxychloroquine Z. Drebert, R. Kashambwa
232 [GO] 2020―Dec―11 PIN56 Cost of COVID-19 Patients Treatment in Turkey E.B. Karahan, S. Öztopçu, M. Kurnaz, S. Ökçün, Z. Caliskan, G. Oğuzhan, G. Kockaya
233 [GO] 2020―Dec―11 ML4 Application of Machine Learning Models to Evaluate COVID-19 Related ICU Utilization in a US Population Z. Icten, C. Chan, M. Munsell, J. Menzin
234 [GO] 2020―Dec―11 PNS198 Arogya Setu Mobile Application for COVID-19 Self-Assessment, Education and Participatory Disease Surveillance: Perception Among Medical and Technology University Students. J. Kochuparambil, A. Nidha
235 [GO] 2020―Dec―11 PUK20 Reimbursement Landscape in Europe As Hurdle or Accelerator of HOME Hemodialysis in COVID-19 Times E. Busink, J. Petrovic, D. Kendzia, S. Boeger, C. Apel
236 [GO] 2020―Dec―11 PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population M. Costa, P. Net, D. Proshenska, F. Bianic, F. Guelfucci
237 [GO] 2020―Dec―11 PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population P. Net, M. Costa, D. Proshenska, F. Bianic, F. Guelfucci
238 [GO] 2020―Dec―11 PNS206 Projecting the COVID-19 Weekly Deaths and Hospitalizations for Jefferson County, Kentucky P. Naiya
239 [GO] 2020―Dec―11 PIN3 Chloroquine and Hydroxychloroquine in COVID-19 with or without Azithromycin: A Systematic Review of in Vitro and Clinical Studies M. Jameleddine, N. Harzallah, H. Grati, M.C. Jebali, C. Hamouda
240 [GO] 2020―Dec―11 PMU82 Increasing Importance of Digital CME in a Post COVID-19 World N. Eslami, K. Infante, B. Harris, G. Erickson, C. Hoyvald, S. Garfield
241 [GO] 2020―Dec―11 PMU5 The Future of Market Access in a Post COVID-19 World - What Do WE Need to Do Differently? C. Teale, S. Morrison, R. Zeidman, R. Tolley, L. Flemingq
242 [GO] 2020―Dec―11 PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives K. Skaltsa, C. Ivanescu, M. Reaney
243 [GO] 2020―Dec―11 PIN110 Socioeconomic Factors Impacting COVID-19-Related Mortality in the United States E. Ridgway, N. Savant, G. Pauletti, J.A. Pieper, P. Juang
244 [GO] 2020―Dec―11 PMU59 The IMPACT of COVID-19: A Comparison of the Number of Regulatory and Health Technology Assessments between the First SIX Months of 2019 and 2020 M. Salvador, K.E. Young
245 [GO] 2020―Dec―11 PIN70 Knowledge Towards Universal Safety Precautions Among Healthcare Population in India during Initial Phase of COVID-19: A Web Based Survey J. Kochuparambil, A. Issac, S. George, N.K. Panicker
246 [GO] 2020―Dec―11 PRS81 Insights into the Coronavirus Disease Perceptions in Pakistan W. Ullah, H. Almansour, G. Victor, S. Hussain, A.J. Pienaar
247 [GO] 2020―Dec―11 CL4 Concerns, Quality of Life, Access to Care and Productivity of the General Population during the First 8 WEEKS of the Coronavirus Lockdown in Belgium and the Netherlands R. Michels, L.M.A. Goossens, R. Bruin, H. van Ballegooijen, M. Krol
248 [GO] 2020―Dec―11 PIN153 Lessons Learned from Economic Models of Influenza Vaccines and Applications to SARS-CoV-2 J. Benner, N. Adair, M. Friedman, J. Menzin, M. Sussman
249 [GO] 2020―Dec―11 PMU28 Multimodal Strategy to Control and Mitigate a Sars-COV-2 Epidemic Outbreak in the Emergency Service of Highly Complex Hospital in Santiago De Chile M. Galvez, J. Retamal, M. Chepo, K. Mondaca, C. Silva, N. Febré
250 [GO] 2020―Dec―11 PRS65 US Sars-COV-2 Geospatial Predictive Weather Mapping MODEL: Application of Machine Learned Bayesian Networks to Healthcare Decision Making J. Vanderpuye-Orgle, D. Erim, M. Maruszczak, S. Pandey, A. Shields, M. Keywood, et al. (+2)
251 [GO] 2020―Dec―11 PIN71 Comparison of Seasonality of Common Viral and Respiratory Diseases VS Emergence of Sars-COV-2 Infection D. Krishnan, C. Holy, S. Shah, N. Elangovanraaj, S. Gupta, P. Trivedi, et al. (+3)
252 [GO] 2020―Dec―11 PIN74 The Impact of Social Distancing on Sars-COV-2 Mortality: A US Analysis A. Gurubaran, C. Holy, S. Shah, B. Nandi, H. Dwarakanathan, A. Bhardwaj, et al. (+2)
253 [GO] 2020―Dec―11 PIN115 Understanding Sars-COV-2 Mortality: IMPACT of Population and Mobility Metrics S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
254 [GO] 2020―Dec―11 PIN111 Predicting the Decline in Sars-COV-2 New Infections: A Modelling Analysis of US Counties H. Dwarakanathan, O. Kakade, A. Bhardwaj, C. Holy, A. Gurubaran, S. Shah, P. Coplan
255 [GO] 2020―Dec―11 PRS58 IMPACT of Sars-COV-2 on Provided Healthcare. Evidence from the Emergency Phase in Italy. R. Di Bidino, A. Cicchetti
256 [GO] 2020―Dec―11 CO4 An Evaluation of the Differences in Vaccine Approval and Procurement Processes between Healthcare Systems during a Pandemic A. Robert, J. Farrington, L. Longworth
257 [GO] 2020―Dec―11 PIN145 Online- Education in Times of Pandemic a Strategy That Allows Change in Times of Crisis, an Example in Chile. N. Febré, V. Nasabun Flores, M.V. Badilla, S. Contreras, T. Pavlov, L.R. Diaz-Diaz, P. Ivanovic
258 [GO] 2020―Dec―11 PR3 Patient-Reported Outcome Measures to Prioritize Surgical Lists during Pandemic Events S. De Rosis, D.A. Lungu, F. Pennucci, S. Nuti
259 [GO] 2020―Dec―11 PCV81 Virtual Anticoagulation Clinic Care a Telehealth MODEL to Deliver Continuity of Anticoagulation Care during the COVID 19 Pandemic: Insights from Southern India O. Gona, S.K. S, R. Madhan
260 [GO] 2020―Dec―10 Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe Leshno
261 [GO] 2020―Oct―13 The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19) C. Daniel Mullins, Michael F. Drummond
262 [GO] 2020―Oct―05 Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group Joy Leahy, Conor Hickey, David McConnell, Owen Cassidy, Lea Trela-Larsen, Michael Barry, et al. (+2)
263 [GO] 2020―Sep―06 Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations Dalia M Dawoud, Khaled Y Soliman
264 [GO] 2020―Sep―04 Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study Shelby Reed, Juan Marcos Gonzalez, F. Reed Johnson
265 [GO] 2020―Aug―27 Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the UK Darshan Zala, Iris Mosweu, Simone Critchlow, Renee Romeo, Paul McCrone
266 [GO] 2020―Jul―27 Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China Siyu Ma, David D. Kim, Joshua T. Cohen, Peter J. Neumann
267 [GO] 2020―May―21 The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable Steven Forsythe, Joshua Cohen, Peter Neumann, Stefano M. Bertozzi, Anthony Kinghorn


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.007 sec